COVID-19 Molecular Testing & Whole Viral Genome Sequencing in a CLIA Certified Lab
Yale Pathology Labs are leaders in COVID-19 (SARS-CoV-2) testing. Since the onset of the pandemic, through today and into the future, Yale Pathology Labs has and will continue to offer leading-edge technologies.
Clients include large universities, private companies, and professional athletic teams.
SARS-CoV-2 Genome Sequencing
- Sequencing available for both nasal and saliva samples
- Rapid turnaround time
- Laboratory Developed Test (LDT) in CLIA certified lab
- Variant detection sequencing by whole genome analysis
- Identified variants/lineage shared with client in standardized report
Gold-standard PCR Testing for SARS-CoV-2
Nasal Swab
- Anterior nasal and nasopharyngeal
- All supplies provided
Saliva
- First lab in CT to offer FDA EUA approved Saliva based PCR test; September 2020
- Performed the clinical validation for the FDA EUA; approved August 2020
- Non-invasive, easy to self-collect
- All supplies provided
Why choose Yale Pathology Labs?
- Dedicated Outreach Service Team
- 24-48 hour turn around for PCR tests
- All positive cases called to client immediately
- Highest standards of quality control and safety; all low positive cases repeated
- Web-based, ordering and reporting portal
Download Information Sheet
Click here to download a PDF Information Sheet for COVID-19 Molecular Testing & Whole Viral Genome Sequencing in a CLIA Certified Lab at Yale Pathology Labs.
Learn more:
Stephanie Weirsman, Director, Reference Services Business Development